In parallel, a single-point mutation in one of the CD95 alleles was shown to convert CD95 from a tumor suppressor to a tumor promotor, a situation frequently observed in advanced human cancer [285,296,297,298,299,300,301,302,303]. This evidence concerns the gene FAS and cancer.